Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Huh

Showing results (321-330 of 365) with videos related to

Pageof 37
Sort By:
Gynecologic Oncology Reports|January 15, 2020
Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)Alessandro D Santin, Virginia Filiaci, Stefania Bellone, et al.
Gynecologic Oncology|July 10, 2020
Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group studyWarner K Huh, William E Brady, Paula M Fracasso, et al.
Gynecologic Oncology|January 29, 2002
Conservative management of stage I endometrial carcinoma after surgical stagingJ Michael Straughn, Warner K Huh, F Joseph Kelly, et al.
Journal of Lower Genital Tract Disease|September 28, 2017
ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing StandardsAlan G Waxman, Christine Conageski, Michelle I Silver, et al.
Gynecologic Oncology|April 26, 2003
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapyJ Michael Straughn, Warner K Huh, James W Orr, et al.
Journal of Lower Genital Tract Disease|January 10, 2015
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceWarner K Huh, Kevin A Ault, David Chelmow, et al.
Gynecologic Oncology|January 13, 2015
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceWarner K Huh, Kevin A Ault, David Chelmow, et al.
Obstetrics and Gynecology|May 2, 2007
Clinical and pathologic correlates in surgical stage II endometrial carcinomaDavid E Cohn, Emily M Woeste, Stacey Cacchio, et al.
Obstetrics and Gynecology|December 2, 2014
Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancerBritt K Erickson, Isaac Kinde, Zachary C Dobbin, et al.
Gynecologic Oncology|December 1, 2015
A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3)Ronald D Alvarez, Warner K Huh, Sejong Bae, et al.
Pageof 37

Showing results (321-330 of 365) with videos related to

Sort By:
Pageof 37
Gynecologic Oncology Reports|January 15, 2020
Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)Alessandro D Santin, Virginia Filiaci, Stefania Bellone, et al.
Gynecologic Oncology|July 10, 2020
Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group studyWarner K Huh, William E Brady, Paula M Fracasso, et al.
Gynecologic Oncology|January 29, 2002
Conservative management of stage I endometrial carcinoma after surgical stagingJ Michael Straughn, Warner K Huh, F Joseph Kelly, et al.
Journal of Lower Genital Tract Disease|September 28, 2017
ASCCP Colposcopy Standards: How Do We Perform Colposcopy? Implications for Establishing StandardsAlan G Waxman, Christine Conageski, Michelle I Silver, et al.
Gynecologic Oncology|April 26, 2003
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapyJ Michael Straughn, Warner K Huh, James W Orr, et al.
Journal of Lower Genital Tract Disease|January 10, 2015
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceWarner K Huh, Kevin A Ault, David Chelmow, et al.
Gynecologic Oncology|January 13, 2015
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceWarner K Huh, Kevin A Ault, David Chelmow, et al.
Obstetrics and Gynecology|May 2, 2007
Clinical and pathologic correlates in surgical stage II endometrial carcinomaDavid E Cohn, Emily M Woeste, Stacey Cacchio, et al.
Obstetrics and Gynecology|December 2, 2014
Detection of somatic TP53 mutations in tampons of patients with high-grade serous ovarian cancerBritt K Erickson, Isaac Kinde, Zachary C Dobbin, et al.
Gynecologic Oncology|December 1, 2015
A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3)Ronald D Alvarez, Warner K Huh, Sejong Bae, et al.
Pageof 37